{"id":7412,"date":"2023-01-26T17:13:23","date_gmt":"2023-01-26T22:13:23","guid":{"rendered":"https:\/\/groupedevonian.com\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/"},"modified":"2024-01-05T10:07:16","modified_gmt":"2024-01-05T15:07:16","slug":"groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference","status":"publish","type":"post","link":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/","title":{"rendered":"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference"},"content":{"rendered":"

COMMUNIQU\u00c9 DE PRESSE Pour diffusion imm\u00e9diate <\/em><\/p>\n

\u00a0<\/h1>\n

GROUPE SANT\u00c9 DEVONIAN ANNONCE SA PARTICIPATION \u00c0 BIO CEO & INVESTOR CONFERENCE<\/h1>\n

QU\u00c9BEC, le\u00a0 26 janvier, 2023\u2013 <\/strong>Groupe Sant\u00e9 Devonian Inc. (\u00ab Devonian \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb) (TSXv: GSD ; OTCQB: DVHGF), <\/strong>une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l\u2019\u00e9laboration d\u2019un portefeuille unique de m\u00e9dicaments d\u2019ordonnance et de produits cosm\u00e9ceutiques d\u2019origine botanique, a le plaisir d’annoncer que M. Pierre Montanaro, pr\u00e9sident et chef de la direction de la Soci\u00e9t\u00e9, fera une pr\u00e9sentation \u00e0 la BIO CEO & Investor Conference qui aura lieu au New York Marriott Marquis du 6 au 9 f\u00e9vrier 2023.La pr\u00e9sentation de la Soci\u00e9t\u00e9 est pr\u00e9vue le mardi 7 f\u00e9vrier \u00e0 16 h 30 (HE) dans la salle Palace au 6e \u00e9tage du Marriott Marquis Times Square. La pr\u00e9sentation de M. Montanaro comprendra un aper\u00e7u du programme de d\u00e9veloppement clinique du Thykamine\u2122, le produit phare de Devonian.La Soci\u00e9t\u00e9 sera disponible pour des r\u00e9unions avec les participants \u00e0 la conf\u00e9rence. Les personnes int\u00e9ress\u00e9es \u00e0 planifier une r\u00e9union peuvent le faire via le syst\u00e8me de partenariat BIO One-on-One : https:\/\/www.bio.org\/events\/bio-ceo-investor-digital-conference\/partnering<\/a> , ou en envoyant un courriel en utilisant les informations fournies \u00e0 la fin de ce communiqu\u00e9 de presse.<\/p>\n

\u00c0 propos du Bio CEO & Investor Conference<\/strong><\/p>\n

Maintenant dans sa 25e ann\u00e9e, la BIO CEO & Investor Conference alimente l’industrie de la biotechnologie en tant qu’\u00e9v\u00e9nement de premier plan pour les cadres sup\u00e9rieurs, les investisseurs et les milieux bancaires, ax\u00e9 sur les soci\u00e9t\u00e9s de biotechnologie priv\u00e9es \u00e9tablies et \u00e9mergentes cot\u00e9es en bourse.Se d\u00e9roulant \u00e0 New York du 6 au 9 f\u00e9vrier, cette conf\u00e9rence est l’une des plus importantes conf\u00e9rences d’investisseurs o\u00f9 les investisseurs institutionnels, les analystes de l’industrie et les cadres sup\u00e9rieurs des soci\u00e9t\u00e9s biotechnologiques ont la possibilit\u00e9 de fa\u00e7onner le futur paysage de l\u2019investissement dans l’industrie de la biotechnologie par le biais de de partenariats, de pr\u00e9sentations des entreprises, de s\u00e9ances \u00e9ducatives sur les progr\u00e8s th\u00e9rapeutiques, les perspectives du march\u00e9 et les priorit\u00e9s politiques.<\/p>\n

Au sujet de Devonian<\/strong><\/p>\n

Groupe Sant\u00e9 Devonian Inc. est une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement qui emploie une strat\u00e9gie novatrice ciblant des besoins m\u00e9dicaux non combl\u00e9s. La principale strat\u00e9gie de Devonian est de d\u00e9velopper des m\u00e9dicaments d\u2019ordonnance d\u2019origine botanique pour le traitement des maladies inflammatoires auto-immunes incluant, mais sans s\u2019y limiter, la colite ulc\u00e9reuse et la dermatite atopique. Fond\u00e9 sur une assise de 15 ann\u00e9es de recherche, l\u2019objectif de Devonian est \u00e9galement appuy\u00e9 par les directives r\u00e9glementaires de la FDA, l\u2019agence am\u00e9ricaine des produits alimentaires et m\u00e9dicamenteux, favorisant un processus de d\u00e9veloppement de produits m\u00e9dicamenteux botaniques d\u2019ordonnance plus efficient que celui des m\u00e9dicaments d\u2019ordonnance classique.<\/p>\n

Devonian est \u00e9galement impliqu\u00e9e dans le d\u00e9veloppement de produits cosm\u00e9ceutiques de grande valeur en s’appuyant sur la m\u00eame approche exclusive que celle utilis\u00e9e avec leurs offres pharmaceutiques.<\/p>\n

Devonian est cot\u00e9e \u00e0 la Bourse de croissance TSX (TSXv:GSD<\/strong>) ainsi que sur la bourse de croissance OTCQB (OTCQB\u00a0: DVHGF<\/strong>).<\/p>\n

Pour plus de d\u00e9tails, visitez le www.groupedevonian.com<\/a><\/p>\n

\u00c9nonc\u00e9s prospectifs<\/strong><\/p>\n

Le pr\u00e9sent communiqu\u00e9 renferme des \u00e9nonc\u00e9s prospectifs sur les objectifs, les strat\u00e9gies et les activit\u00e9s de Devonian. Ces \u00e9nonc\u00e9s prospectifs sont assujettis \u00e0 certains risques et incertitudes. Ces \u00e9nonc\u00e9s sont de nature \u00ab\u2009prospective\u2009\u00bb puisqu\u2019ils sont fond\u00e9s sur nos attentes pr\u00e9sentes \u00e0 l\u2019\u00e9gard des march\u00e9s dans lesquels nous exer\u00e7ons nos activit\u00e9s et sur diverses estimations et hypoth\u00e8ses. Les \u00e9v\u00e9nements ou les r\u00e9sultats r\u00e9els sont susceptibles de diff\u00e9rer consid\u00e9rablement de ceux pr\u00e9vus dans le cadre des \u00e9nonc\u00e9s prospectifs si des risques connus ou inconnus affectent nos activit\u00e9s ou si nos estimations ou nos hypoth\u00e8ses s\u2019av\u00e8rent inexactes. Ces risques, estimations et hypoth\u00e8ses incluent, mais sans s\u2019y limiter, l\u2019approbation de la Bourse de croissance TSX en lien avec l\u2019\u00e9mission des Unit\u00e9s, la capacit\u00e9 de Devonian d\u2019assurer le d\u00e9veloppement, la fabrication et la commercialisation de produits pharmaceutiques et dermo-cosm\u00e9tiques \u00e0 valeur ajout\u00e9e, la disponibilit\u00e9 de ressources financi\u00e8res pour mener \u00e0 bien des projets de recherche et d\u00e9veloppement, le succ\u00e8s et la dur\u00e9e d\u2019\u00e9tudes cliniques, la capacit\u00e9 de Devonian de se pr\u00e9valoir des occasions d\u2019affaires dans l\u2019industrie pharmaceutique et dermo-cosm\u00e9tique, les incertitudes li\u00e9es au processus de r\u00e9glementation et tout changement du contexte \u00e9conomique. Vous trouverez une analyse plus exhaustive des risques qui pourraient faire en sorte que les \u00e9v\u00e9nements ou r\u00e9sultats r\u00e9els diff\u00e8rent de nos attentes pr\u00e9sentes de fa\u00e7on importante dans le prospectus en date du 21 avril 2017, sous la rubrique \u00ab\u2009Facteurs de risque\u2009\u00bb. Par cons\u00e9quent, nous ne pouvons garantir la r\u00e9alisation des \u00e9nonc\u00e9s prospectifs. Par ailleurs, nous ne nous engageons aucunement \u00e0 mettre \u00e0 jour ces \u00e9nonc\u00e9s prospectifs, m\u00eame si de nouveaux renseignements devenaient disponibles, \u00e0 la suite d\u2019\u00e9v\u00e9nements futurs ou pour toute autre raison, \u00e0 moins d\u2019y \u00eatre tenus en vertu des lois et r\u00e8glements applicables aux valeurs mobili\u00e8res.<\/p>\n

La Bourse de croissance TSX et son fournisseur de services de r\u00e9glementation (au sens attribu\u00e9 \u00e0 ce terme dans les politiques de la Bourse de croissance TSX) n\u2019assument aucune responsabilit\u00e9 quant \u00e0 la pertinence ou \u00e0 l\u2019exactitude du pr\u00e9sent communiqu\u00e9.<\/em><\/p>\n

CONTACT:<\/strong><\/p>\n

Pierre Montanaro
Pr\u00e9sident et chef de la direction
Tel.: (514) 909-3788
Courriel\u00a0: pmontanaro@groupedevonian.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

COMMUNIQU\u00c9 DE PRESSE Pour diffusion imm\u00e9diate \u00a0 GROUPE SANT\u00c9 DEVONIAN ANNONCE SA PARTICIPATION \u00c0 BIO CEO & INVESTOR CONFERENCE QU\u00c9BEC, le\u00a0 26 janvier, 2023\u2013 Groupe Sant\u00e9 Devonian Inc. (\u00ab Devonian \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb) (TSXv: GSD ; OTCQB: DVHGF), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l\u2019\u00e9laboration d\u2019un portefeuille […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[71,35],"tags":[],"class_list":["post-7412","post","type-post","status-publish","format-standard","hentry","category-2023-fr","category-communiques-de-presse"],"yoast_head":"\nGroupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference - DEVONIAN HEALTH GROUP INC.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference - DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"og:description\" content=\"COMMUNIQU\u00c9 DE PRESSE Pour diffusion imm\u00e9diate \u00a0 GROUPE SANT\u00c9 DEVONIAN ANNONCE SA PARTICIPATION \u00c0 BIO CEO & INVESTOR CONFERENCE QU\u00c9BEC, le\u00a0 26 janvier, 2023\u2013 Groupe Sant\u00e9 Devonian Inc. (\u00ab Devonian \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb) (TSXv: GSD ; OTCQB: DVHGF), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l\u2019\u00e9laboration d\u2019un portefeuille […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"DEVONIAN HEALTH GROUP INC.\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-26T22:13:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-05T15:07:16+00:00\" \/>\n<meta name=\"author\" content=\"acxdev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"acxdev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/\"},\"author\":{\"name\":\"acxdev\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\"},\"headline\":\"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference\",\"datePublished\":\"2023-01-26T22:13:23+00:00\",\"dateModified\":\"2024-01-05T15:07:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/\"},\"wordCount\":969,\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"articleSection\":[\"2023\",\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/\",\"name\":\"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference - DEVONIAN HEALTH GROUP INC.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\"},\"datePublished\":\"2023-01-26T22:13:23+00:00\",\"dateModified\":\"2024-01-05T15:07:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"name\":\"DEVONIAN HEALTH GROUP INC.\",\"description\":\"Botanical pharmaceutical corporation\",\"publisher\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#organization\",\"name\":\"Groupe Sant\u00e9 Devonian inc.\",\"alternateName\":\"Groupe Sant\u00e9 Devonian inc.\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"contentUrl\":\"https:\\\/\\\/groupedevonian.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/logo-devonian-2x.png\",\"width\":309,\"height\":183,\"caption\":\"Groupe Sant\u00e9 Devonian inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/groupedevonian.com\\\/fr\\\/#\\\/schema\\\/person\\\/ff9b4cc2d46ac4fb34e4f4641825f159\",\"name\":\"acxdev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g\",\"caption\":\"acxdev\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference - DEVONIAN HEALTH GROUP INC.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/","og_locale":"fr_FR","og_type":"article","og_title":"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference - DEVONIAN HEALTH GROUP INC.","og_description":"COMMUNIQU\u00c9 DE PRESSE Pour diffusion imm\u00e9diate \u00a0 GROUPE SANT\u00c9 DEVONIAN ANNONCE SA PARTICIPATION \u00c0 BIO CEO & INVESTOR CONFERENCE QU\u00c9BEC, le\u00a0 26 janvier, 2023\u2013 Groupe Sant\u00e9 Devonian Inc. (\u00ab Devonian \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb) (TSXv: GSD ; OTCQB: DVHGF), une soci\u00e9t\u00e9 biopharmaceutique botanique en stade avanc\u00e9 de d\u00e9veloppement ax\u00e9e sur l\u2019\u00e9laboration d\u2019un portefeuille […]","og_url":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/","og_site_name":"DEVONIAN HEALTH GROUP INC.","article_published_time":"2023-01-26T22:13:23+00:00","article_modified_time":"2024-01-05T15:07:16+00:00","author":"acxdev","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"acxdev","Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/#article","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/"},"author":{"name":"acxdev","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159"},"headline":"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference","datePublished":"2023-01-26T22:13:23+00:00","dateModified":"2024-01-05T15:07:16+00:00","mainEntityOfPage":{"@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/"},"wordCount":969,"publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"articleSection":["2023","Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/","url":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/","name":"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference - DEVONIAN HEALTH GROUP INC.","isPartOf":{"@id":"https:\/\/groupedevonian.com\/fr\/#website"},"datePublished":"2023-01-26T22:13:23+00:00","dateModified":"2024-01-05T15:07:16+00:00","breadcrumb":{"@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/groupedevonian.com\/fr\/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/groupedevonian.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Groupe Sant\u00e9 Devonian Annonce sa Participation \u00e0 BIO CEO & Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/groupedevonian.com\/fr\/#website","url":"https:\/\/groupedevonian.com\/fr\/","name":"DEVONIAN HEALTH GROUP INC.","description":"Botanical pharmaceutical corporation","publisher":{"@id":"https:\/\/groupedevonian.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/groupedevonian.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/groupedevonian.com\/fr\/#organization","name":"Groupe Sant\u00e9 Devonian inc.","alternateName":"Groupe Sant\u00e9 Devonian inc.","url":"https:\/\/groupedevonian.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","contentUrl":"https:\/\/groupedevonian.com\/wp-content\/uploads\/2022\/05\/logo-devonian-2x.png","width":309,"height":183,"caption":"Groupe Sant\u00e9 Devonian inc."},"image":{"@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/groupedevonian.com\/fr\/#\/schema\/person\/ff9b4cc2d46ac4fb34e4f4641825f159","name":"acxdev","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c219016bab8405cb8b5caa8f18b852d553cf083471d4e9dd4a71c4d518cc3a1c?s=96&d=mm&r=g","caption":"acxdev"}}]}},"_links":{"self":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/7412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/comments?post=7412"}],"version-history":[{"count":1,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/7412\/revisions"}],"predecessor-version":[{"id":7415,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/posts\/7412\/revisions\/7415"}],"wp:attachment":[{"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/media?parent=7412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/categories?post=7412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/groupedevonian.com\/fr\/wp-json\/wp\/v2\/tags?post=7412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}